Home

Hans van Houte, CFO: Nurix Therapeutics NRIX Sell · Filed 24/07/30

Trade details

Type
Insider sale
Amount
$51,468.3
Shares · price
2,490 sh · $20.67 a share
Held after
54,479 sh
Trade date
24/07/30
Filed
24/07/30
Days to filing
0 days

Sold 4.4% of holdings

Share of holding sold
4.4%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 24/06/30~24/08/29

Hans van Houte's recent trades

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $110.6K

    Filed 08/04

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $223.4K

    Filed 05/05

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $9,999

    Filed 05/05

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $238K

    Filed 05/05

  • Hans van Houte

    SellNurix Therapeutics

    $39.8K

    Filed 04/30